Author

Nathan B. Murray

Hofstra UniversityORCID 0000-0002-0685-722XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexander K. AndrianoviD· 1 shared Alexander MariniD· 1 shared Alexander PloßiD· 1 shared Austin W.T. ChiangiD· 1 shared Bhoj KumariD· 1 shared Bjørn Gunnar Rude VoldborgiD· 1 shared Devika SubramanianiD· 1 shared Eric A. TothiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexander K. AndrianovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicity

Liudmila Kulakova, Kiki H. Li, Austin W.T. Chiang, Michael P. Schwoerer, Sanne Schoffelen, Khadija H. Elkholy, Kinlin L. Chao, Salman Shahid, Bhoj Kumar, Nathan B. Murray, Stephanie A. Archer‐Hartmann, Parastoo Azadi, Bjørn Gunnar Rude Voldborg, Alexander Marin, Roy A. Mariuzza, , Thomas R. Fuerst

This study shows that glycoengineering of HCV E2 glycoprotein affects antigen biochemical properties and immune response, with some glycans improving neutralization potency.

bioRxiv · Apr 2, 2025 · PreprintImmunology

aer2vec: Distributed Representations of Adverse Event Reporting System Data as a Means to Identify Drug/Side-Effect Associations

Jake Portanova, Nathan B. Murray, Justin Mower, Devika Subramanian, Trevor Cohen

This paper introduces aer2vec, a representation learning method for adverse event reporting system data to identify drug/side-effect associations, showing improved performance over traditional disproportionality metrics.

bioRxiv · Oct 2, 2019 · PreprintBioinformatics